Suchergebnisse - "Perrone, Francesco"

PubPharm (5)

1

Effect of bevacizumab in advanced low grade serous ovarian cancer : Data from the MITO 22 trial

enthalten in: Gynecologic oncology | 2023

von Musacchio, L. | Turinetto, M. | Arenare, L. | +18

2

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

enthalten in: Gynecologic oncology | 2019

von Daniele, G. | Arenare, L. | Scambia, G. | +25

3

The MITO CERV-2 trial : A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

enthalten in: Gynecologic oncology | 2019

von Pignata, S. | Scambia, G. | Lorusso, D. | +29

4

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB) : A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

enthalten in: Gynecologic oncology | 2017

von Daniele, G. | Lorusso, D. | Scambia, G. | +20

5

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial

enthalten in: Gynecologic oncology | 2017

von Daniele, G. | Lorusso, D. | Scambia, G. | +20

1
[1]